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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489 S381the Nufﬁeld Orthopaedic Centre (Oxford) between 2010–2012. LoS data
was highly skewed and underwent natural log transformation. Linear
regression methods were used to assess the association between TUG
and LoS after adjustment for age, gender and BMI. To assess whether the
association between preoperative TUG and postoperative LoS was
consistent across operation type an interaction between these two
variables was also included.Table 1
Mean values of baseline characteristics in sample population (n ¼ 534).
Variable Value
Female n (%) 290 (54%)
Male n (%) 244 (46%)
Age (years) 67.5
Male BMI (kg/m2) 28.8
Female BMI (kg/m2) 29.9
Median LoS TKR (days) 4
Median LoS THR (days) 4
Median LoS UKR (days) 2Results: Median length of stay differed signiﬁcantly (unadjusted p <
0.001) according to operation type (Table 1). TKR patients were sig-
niﬁcantly older (mean 3 years p ¼ 0.04) than THR or UKR patients,
which may explain longer LoS. After adjustment for confounding fac-
tors, there was a signiﬁcant association between LoS and TUG (Graph 1)
which differed by operation type (p¼ 0.04). A 10 second increase in TUG
predicted a 19% increase in LoS for TKR patients (p < 0.001), a 12.4%
increase in UKR patients (p ¼ 0.004) and a non-signiﬁcant 5% increase
in THR patients (p ¼ 0.125).Graph 1: The association between length of stay (days) and the timed up
and go test (seconds) in total hip (THR), total knee (TKR) and uni-com-
partmental knee replacement (UKR) patients.
Conclusions: A signiﬁcant association between TUG and LoS was
demonstrated for knee replacement patients. These ﬁndings suggest
that use of tools such as TUG may be a quick and simple method to
enable clinicians and commissioners to plan for resource usage. Con-
sequently, this may have implications on patient care pathways as well
as ﬁnancial signiﬁcance.
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DO PSYCHOLOGICAL FACTORS PREDICT RESPONSE TO INTRA-
ARTICULAR STEROID THERAPY IN KNEE OSTEOARTHRITIS?
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Purpose: Intra-articular steroid therapy is widely used in clinical
practice in the management of knee osteoarthritis (OA) and included in
current management guidelines for the disease. There is a paucity of
data, however, about the inﬂuence of psychological factors on treat-
ment response. Such data are important and may help better targeting
of therapy. The aim of this analysis was to determine whether levels of
anxiety and depression at baseline inﬂuence response to intra-articular
steroid therapy in patients with symptomatic knee OA.
Methods: Men and women aged 40 years and older with painful knee
OA, and who met American College of Rheumatology (ACR) criteria for
the disease, were recruited for participation in an ongoing open-label
clinical trial of intra-articular steroid therapy. Subjects who took part in
the study had signiﬁcant knee pain and had grade 2 (Kellgren-Law-
rence) or higher knee OA. At baseline they completed questionnaires
about their symptoms including the Knee Injury and Osteoarthritis
Outcome Score (KOOS) (0-100), with lower scores indicating greater
pain and also a VAS (0–10) for pain during a nominated activity
(VASnA), with higher scores indicating greater pain. They also com-
pleted the Hospital Anxiety and Depression (HAD) Scale, a 14-item scale
which includes items relating to anxiety and depression both ranging in
total from 0 (none) to 21 (maximum). They subsequently had an intra-
articular steroid injectionwith repeat pain assessments at the follow-up
visit usually within a 2 week period. We used linear regression to look
whether pre-intervention anxiety and depression scores were asso-
ciated with change in pain. We also used between-groups t-tests to
investigate whether these scores differed between responders and non-
responders (according to OARSI-OMERACT criteria).
Results: Eighty-eight patients, mean age 61.2 yrs (SD ¼ 10.2 yrs), of
whom 48 (54.6%) were female, were studied. The median time between
the baseline and follow-up assessment was 8 days (inter-quartile range
7–13 days). There was an increase in KOOS score between baseline and
follow-up (25.2 points; 95% Conﬁdence Interval [CI] 20.5–30.0 points; p
< 0.001) and a reduction in VASnA (3.3 cm; 95% CI 3.9 to 2.6 cm; p
< 0.001), both indicating an improvement in pain symptoms following
steroid injection. Higher anxiety scores at baseline were associated with
less change in pain (following intervention) using KOOS (b coefﬁcient /
per unit change in anxiety score ¼ 1.08; 95% CI 2.16 to 0.01; p ¼
0.049). Higher anxiety levels were weakly positively linked with change
in pain using VASnA (b coefﬁcient ¼ 0.06; 95% CI 0.09–0.22; p ¼ 0.44)
though the conﬁdence intervals included zero. Higher depression
scores at baseline were not associated with a change in pain using KOOS
(b coefﬁcient ¼ 1.07; 95% CI 2.34–0.21; p ¼ 0.10) or change in pain
using VASnA (b coefﬁcient ¼ 0.04; 95% CI 0.14–0.22; p ¼ 0.63). Using
the OARSI-OMERACT criteria 62 (70.5%) patients were responders.
Those who responded had lower anxiety scores than those who did not
respond (mean score ¼ 5.96 vs 7.43; p ¼ 0.15) and lower depression
scores (mean score ¼ 4.16 vs 4.64; p ¼ 0.18); however, these differences
were not statistically signiﬁcant.
Conclusion: Adverse psychological factors, especially anxiety, appear to
limit response to intra-articular steroid treatment in patients with
symptomatic knee OA.
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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S382Purpose: While knee osteoarthritis (KOA) is typically a slowly pro-
gressive disorder, it has recently been appreciated that 5–17% of knees
progress rapidly (e.g. from normal to end-stage structural damage
within 4 years). Unfortunately, little is known about risk factors for this
phenotype of OA. Understanding the differences among individuals
with rapid KOA, non-rapid KOA, or no KOA may inform prognostic
testing, pre-emptive interventions, and increase our understanding of
the nature of KOA progression. Therefore, we compared baseline
descriptive characteristics among individuals who develop rapid KOA,
non-rapid KOA, or no KOA within the Osteoarthritis Initiative.
Methods: In the Osteoarthritis Initiative (OAI) we only studied partic-
ipants free of any knee OA on their baseline radiographs (Kellgren-
Lawrence [KL] < 2). We compared three groups: 1) rapid KOA: at least
one knee progressed to end-stage KOA (KL Grade 3 or 4) within 48
months, 2) non-rapid progression: at least one knee increased inTable. Baseline Descriptive Characteristics of Individuals with and without Rapid Knee Osteoarthritis (KOA) Progression.
No KOA (n ¼ 1325)
n (%) or mean (SD)
Non-rapid KOA (n ¼ 187)
n (%) or mean (SD)
Rapid KOA (n ¼ 54)
n (%) or mean (SD)
Univariate
Analyses1 p-value
Females 759 (57.3%) 122 (65.2%) 34 (63.0%) 0.0932
Race other than white (n miss ¼ 2) 177 (13.4%) 34 (18.2%) 8 (14.8%) 0.205
Age (years) 59.2 (9.2) 58.0 (8.3) 61.8 (8.6) 0.0232
BMI (kg/m2) 27.1 (4.4) 27.8 (4.5) 28.9 (4.7) 0.0022
Abnormal Weight Circumference (n miss ¼ 78) 847 (67.2%) 127 (73.0%) 40 (74.1%) 0.197
Systolic blood pressure (mm Hg) 121.1 (15.9) 118.4 (13.1) 123.1 (14.1) 0.0472
Fallen in past 12 mo (n miss ¼ 27) 433 (33.2%) 63 (34.4%) 21 (41.2%) 0.479
Static knee malalignment (Varus or valgus, n miss ¼ 79)3 992 (78.9%) 122 (69.7%) 40 (74.1%) 0.0202
Socio-economic Status
No health insurance THAT covers Rx (n miss ¼ 23) 117 (8.9%) 12 (6.6%) 8 (15.7%) 0.126
Income < $50K (n miss ¼ 52) 403 (31.4%) 48 (27.0%) 22 (43.1%) 0.0872
Less than a College Degree (n miss ¼ 8) 434 (32.9%) 73 (39.5%) 16 (30.8%) 0.186
Self-reported health assessments
Frequent knee pain on most days of a month
in past year (n miss ¼ 1)
502 (37.9%) 77 (41.2%) 25 (46.3%) 0.344
WOMAC pain Score 2.2 (2.8) 2.1 (2.6) 2.7 (3.0) 0.346
Charlson Comorbidity Score > 0 (n miss ¼ 2) 264 (20.1%) 28 (15.2%) 14 (28.0%) 0.0992
SF-12 physical summary score (n miss ¼ 13) 51.5 (7.8) 51.7 (7.6) 50.8 (9.7) 0.773
SF-12 Mental Summary Score (n miss ¼ 13) 53.4 (7.5) 53.8 (7.5) 53.4 (7.7) 0.733
Depression score (CES-D; n miss ¼ 11) 6.0 (6.3) 5.6 (6.1) 6.1 (5.9) 0.708
Physical activity score (PASE score ; n miss ¼ 7) 169 (82) 177 (82) 182 (91) 0.250
Other Joints
Right hand bony enlargements (n miss ¼ 20) 697 (53.4%) 107 (57.5%) 31 (57.4%) 0.498
Left hand bone enlargements (n miss ¼ 21) 617 (47.3%) 93 (50.0%) 32 (59.3%) 0.191
Any back pain, past 30 days (n miss ¼ 2) 781 (59.0%) 99 (52.9%) 36 (66.7%) 0.134
Doctor diagnosed back OA (n miss ¼ 55) 190 (14.9%) 30 (16.5%) 11 (22.0%) 0.346
Doctor diagnosed hip OA (n miss ¼ 44) 94 (7.3%) 11 (6.0%) 5 (9.8%) 0.624
Doctor diagnosed hand OA (n miss ¼ 44) 215 (16.7%) 21 (11.5%) 9 (17.7%) 0.200
Pharmacological interventions
Either knee, used meds for pain, past 12 mo (n miss ¼ 2) 571 (43.2%) 86 (46.0%) 27(50%) 0.490
Either knee, injection for arthritis, past 6 m (n miss ¼ 1) 13 (1.0%) 4 (2.1%) 2 (3.7%) 0.094
Take any pain medication today (for any pain) 124 (9.4%) 18 (9.6%) 8 (14.8%) 0.410
OTC NSAIDs for joint pain, past 30 days (n miss ¼ 3) 213 (16.1%) 27 (14.6%) 15 (27.8%) 0.0592
Acetaminophen for joint pain, past 30 day (n miss ¼ 2) 112 (8.5%) 12 (6.5%) 7 (13.0%) 0.303
Rx NSAIDs for joint pain, past 30 days (n miss ¼ 1) 56 (4.2%) 9 (4.8%) 1 (1.9%) 0.634
COXIBS for joint pain, past 30 days 86 (6.5%) 9 (4.8%) 4 (7.4%) 0.641
Strong Rx Pain Med for joint pain, past 30 days 29 (2.2%) 3 (1.6%) 0 (0.0%) 0.485
Note. 1) Chi-squares and analyses of variance (with Tukey HSD post-hoc comparisons as needed). 2) Variables that were explored in more advanced analyses. 3) Static
malalignment based on a clinical examination with a goniometer. CES-D ¼ Center for Epidemiologic Study Depression Scale Score; PASE ¼ Physical Activity Scale for the
Elderly; OTC ¼ over the counter; NSAIDs ¼ nonsteroidal anti-inﬂammatory drugs; Rx ¼ Prescription; COXIBS ¼ COX-2 selective nonsteroidal anti-inﬂammatory drugs.radiographic scoring within 48 months (excluding those deﬁned as
rapid KOA), and 3) No KOA: no change in KL grade by 48-month follow-
up. Self-reported and objective measures (see table) were acquired
based on a standard protocol. We ﬁrst evaluated the distribution of
baseline descriptive characteristics among the three groups with Chi-
square tests or analyses of variance (with Tukey HSD post-hoc com-
parisons as needed). Based on the initial analyses we entered baseline
descriptive characteristics that may distinguish individuals with rapid
KOA (i.e. variables with p values< 0.10 and a sufﬁcient sample size) into
a multinomial stepwise logistic regression model to determine if they
were associated with rapid KOA as an outcome compared with no KOA
or non-rapid KOA.
Results: Individuals with rapid KOA tended to be older and have greater
baseline body mass index (BMI) and systolic blood pressure (see Table).
After adjusting for evaluated sex, systolic blood pressure, income,presence of comorbidity, static knee malalignment, and use of over-the-
counter nonsteroidal anti-inﬂammatory drugs, only baseline age (odds
ratio [OR]¼ 1.04, 95% conﬁdence interval [CI]¼ 1.01–1.08; per year) and
BMI (OR ¼ 1.10, 95% CI ¼ 1.03–1.17; per kg/m2) were greater among
individuals with rapid KOA compared with those with no KOA. In
comparison with individuals with non-rapid KOA, only age was asso-
ciated with developing rapid KOA (OR ¼ 1.05, 95% CI ¼ 1.01–1.09; per
year).
Conclusions: Among individuals with no radiographic KOA, those who
develop rapid KOA tended to be older than those with no KOA or non-
rapid KOA. Furthermore, individuals with rapid KOA tended to have a
higher BMI than those with no KOA. While we often discuss rapid onset
of KOA among young individuals with a history of knee injury we must
not lose sight that older individuals may also be at risk for rapid KOA.679
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Purpose: Obesity is strongly linked to knee OA and is considered a
risk factor for both incidence and progression. Obese patients with
knee OA tend to walk slower, have shorter step length, cadence
and single limb support (SLS). Most obese patients fail to comply
